CervoMed Inc. Notes Payable
CervoMed Inc. (CRVO) had Notes Payable of $715.00 thousand as of 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:NotesPayable · last filed 2014-08-14
- 2014-06-30: Notes Payable $715.00K.
- 2014-03-31: Notes Payable $2.93M.
- 2013-12-31: Notes Payable $1.67M; Notes Payable as first filed $1.87M.
- 2013-09-30: Notes Payable $2.58M.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2014-06-30 | $715.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $2.93M 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $1.67M 10-Q · filed 2014-08-14 | $1.87M 10-K/A · filed 2014-04-23 |
| 2013-09-30 | $2.58M 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $2.08M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $4.22M 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $4.00M 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $3.43M 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $2.75M 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $555.00K 10-Q · filed 2012-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |